ArtPred
's-hertogenbosch
About ArtPred
ARTPred is a research driven biotech company in the field of IVF. ARTPred is dedicated to develop a predictive test (PREDICTIFE) for embryo implantation, ased on urinary and vaginal microbiome profiling. It is the mission of ARTPred to make our unique technology available for all IVF patients worldwide in order to avoid unnecessary treatment burden.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $294.8K
- Last round: Grant (Jan 2015)
- Website: artpred.com
- Phone: +31620409729
Industries & Categories
Biopharma, Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/artpred-3657547 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.